Merck, Daiichi Sankyo withdraw US appication for patritumab deruxtecan for advanced or metastatic EGFR-mutated non-small cell lung cancer Ruchika Sharma31 May 2025 3:18 PM ISTRahway: Daiichi Sankyo and Merck, known as MSD outside of the United States and Canada, have announced that the Biologics License Application...
Early-Stage Lung Cancer Linked to Nodular Wall Thickening in Cystic Lung Lesions: Study Jacinthlyn Sylvia30 May 2025 8:30 PM ISTA recent study published in the journal of Radiology revealed that certain imaging features of cystic lung lesions, specifically those with nodular...
Bayer Sevabertinib gets USFDA Priority Review status for HER2-mutant non-small cell lung cancer Ruchika Sharma29 May 2025 11:15 AM ISTBerlin: Bayer has received Priority Review status from the US Food and Drug Administration (FDA) for the investigational compound sevabertinib...
Deep learning can predict lung cancer risk from single LDCT scan, finds study Dr. Kamal Kant Kohli27 May 2025 9:00 PM ISTA deep learning model was able to predict future lung cancer risk from a single low-dose chest CT scan, according to new research published at the ATS...
Pfizer strikes cancer drug deal with China's 3SBio Ruchika Sharma20 May 2025 11:30 AM IST3SBio plans to initiate the first Phase 3 study in China in 2025.
Roche receives USFDA approval for VENTANA MET (SP44) RxDx Assay as companion diagnostic in non-small cell lung cancer Ruchika Sharma18 May 2025 2:30 PM ISTBasel: Roche has announced that the FDA has approved the VENTANA MET (SP44) RxDx Assay, the first companion diagnostic approved to aid in determining...
Bristol Myers Squibb bags European Commission approval for Opdivo combo in lung cancer treatment Ruchika Sharma18 May 2025 11:45 AM ISTPrinceton: Bristol Myers Squibb has announced that the European Commission (EC) has approved the perioperative regimen of neoadjuvant...
AbbVie Emrelis gets USFDA accelerated approval for a type of lung cancer Ruchika Sharma15 May 2025 11:10 AM ISTNorth Chicago: AbbVie has received accelerated approval from the U.S. Food and Drug Administration (FDA) for EMRELIS (telisotuzumab...
New radiotherapy technique may protect heart during lung cancer treatment: Study Dr. Kamal Kant Kohli14 May 2025 9:00 PM ISTA new study presented at ESTRO 2025 introduces the RAPID-RT study, which uses an innovative rapid-learning approach to evaluate the impact of...
GSK, partner iTeos end development programme for lung cancer drug belrestotug Ruchika Sharma14 May 2025 2:30 PM ISTGSK plc with its development partner iTeos Therapeutics, Inc., has announced that it is ending the development programme for experimental lung cancer...
Medical Bulletin 05/ May/ 2025 Dr. Garima Soni5 May 2025 3:00 PM ISTHere are the top medical news for the day:Too Much Chicken? New Research Finds Link to Increased Risk of Early DeathA recent study published in the...
AI-Enabled X-Rays Help Detect Lung Cancer Risk in 50,000 Patients Worldwide: Study Shows Dr. Garima Soni5 May 2025 8:30 AM ISTAstraZeneca, in partnership with health-tech company Qure.ai, has successfully completed over 5 million artificial intelligence (AI)-enabled chest...
